openPR Logo
Press release

Glaucoma – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2018 | Bausch Health Companies Inc., Alcon, Aerie Pharmaceuticals, Shire, Ohr Pharmaceutical Inc, Santen, Santen Pharmaceutical, Nicox, Allergan

04-17-2019 12:55 PM CET | Health & Medicine

Press release from: Glaucoma Competitive Landscape- Pharma Proff

Glaucoma – Competitive Landscape, Epidemiology Forecast,

Glaucoma refers to a group of diseases that tend to damage the optic nerve, resulting in vision loss and blindness. It is usually caused due to fluid building up in the anterior part of the eye, which increases pressure inside the eye. It can affect people of all ages but is most common in adults aged between 70 to 80 years. If not treated, people with glaucoma slowly lose their peripheral vision and miss objects to the side and out of the corner of their eye. Over time, straight-ahead vision may decrease until no vision remains.

Download the sample report at: https://www.pharmaproff.com/request-sample/1157

The report covers disease overview along with currently available diagnostic and treatment methods; detailed product profiles of pipeline assets; and segmentation of pipeline assets by company, phase of development, route of administration (RoA), mechanism of action (MoA), and molecule type.

Get the detailed analysis at: https://www.pharmaproff.com/report/glaucoma
Highlights of the report:

• Vyzulta, manufactured and marketed by Bausch Health Companies Inc. has been approved by the USFDA (Food and Drug Administration) for the treatment of glaucoma.
• There are approximately 10+ drugs in the glaucoma pipeline.
• Vyzulta by Bausch Health Companies Inc., Azopt by Alcon Laboratories Inc., and Rhopressa by Aerie Pharmaceuticals Inc., are some key drug candidates in the pipeline. Other prominent players include Shire plc, Ohr Pharmaceutical Inc., Santen Pharmaceutical Co. Ltd., Nicox S.A., and Allergan plc.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1157

Coverage of marketed and pipeline research activities on glaucoma report:
Comprehensive product profiles of marketed and pipeline products covering their research and development activities; regulatory milestones of marketed products; and competitive landscape of other strategic development affairs outlining drug designations, collaboration, and licensing details, mergers and acquisitions, patent information, and technology used.

Recent and upcoming strategic development activities and therapeutic segmentation in the report:
This part of the report covers details about the key recent and upcoming national and international conferences in the year. Also provided is the segmentation of marketed therapeutic assets by region, pipeline therapeutic assets by clinical trial region and status, attribute analysis, and launch timeline analysis of higher phase products (Filed, Phase III).

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glaucoma – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2018 | Bausch Health Companies Inc., Alcon, Aerie Pharmaceuticals, Shire, Ohr Pharmaceutical Inc, Santen, Santen Pharmaceutical, Nicox, Allergan here

News-ID: 1706994 • Views: 748

More Releases for Pharmaceutical

Pharmaceutical Packaging Equipment Market
The Global Pharmaceutical Packaging Equipment Market is expected to grow from USD 62235.24 Millions in 2018 to USD 98562.24 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.78%. Get Free Sample: https://reports.valuates.com/request/sample/360I-Auto-4F48/Global_Pharmaceutical_Packaging_Equipment "Growing pharmaceutical industry in emerging economies is one of the factors largely attributing to the growth of the Global Pharmaceutical Packaging Equipment Market " View Full Report: https://reports.valuates.com/market-reports/360I-Auto-4F48/global-pharmaceutical-packaging The factors attributing to the growth of the
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market